HistopathologicaI H&E-Based evaluation of HER2 status in breast cancer through a novel machine learning approach
DESCRIPTION
Recent evidences introduced a new ‘HER2-low’ expression in breast cancer (BC) clinical practice1. The accurate definition of the HER2 profile is thus showing the need for more sensitive diagnostic tools to ensure that eligible patients are not deprived of effective therapies.
